about
The use of psychotropic medication during pregnancy: how about the newborn?Substance use during pregnancyMethodological Issues in Assessing the Impact of Prenatal Drug ExposurePharmacologic management of the opioid neonatal abstinence syndromeNeonatal painAttachment Theory and Maternal Drug Addiction: The Contribution to Parenting InterventionsOpioids in pregnancy and neonatal abstinence syndromeThe opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic.Neonatal drug withdrawal syndrome: cross-country comparison using hospital administrative data in England, the USA, Western Australia and Ontario, Canada.Vibrotactile stimulation: A non-pharmacological intervention for opioid-exposed newborns."Late" Withdrawal Syndrome after Carbamazepine In Utero Exposure in a CYP2C9 Slow Metabolizer Newborn.Rates of Neonatal Abstinence Syndrome Amid Efforts to Combat the Opioid Abuse Epidemic.Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National GuidanceNovel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome.Current management of neonatal abstinence syndrome secondary to intrauterine opioid exposureEpigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndromeReview of the assessment and management of neonatal abstinence syndromeNeonatal abstinence syndrome: essentials for the practitioner.Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance.Detection of codeine, morphine, 6-monoacetylmorphine, and meconin in human umbilical cord tissue: method validation and evidence of in utero heroin exposureEffects of Clonidine on Withdrawal From Long-term Dexmedetomidine in the Pediatric Patient.Neonatal opioid withdrawal and antenatal opioid prescribingPrescription opioid epidemic and infant outcomes.Is periconceptional opioid use safe?Phenobarbital versus morphine in the management of neonatal abstinence syndrome, a randomized control trial.Variations in opioid receptor genes in neonatal abstinence syndromeIncreasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome.Gender Considerations in Addiction: Implications for Treatment.Caring for Opioid-dependent Pregnant Women: Prenatal and Postpartum Care Considerations.Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone.Heart rate variability evaluation in the assessment and management of in-utero drug-exposed infants.Recent trends in treatment admissions for prescription opioid abuse during pregnancyEconomic evaluation of a behavioral intervention versus brief advice for substance use treatment in pregnant women: results from a randomized controlled trial.Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome: A Pilot Study.Substance Use in the Perinatal Period.Neonatal Abstinence Syndrome: Influence of a Combined Inpatient/Outpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population.Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital.
P2860
Q24625025-674E0761-BACB-41D6-A942-78F6A7185FD7Q26745402-2D34F1E7-6AA1-4468-BB7C-030AAAD66BE6Q26775873-B12E787E-A7F8-460A-AD0B-4A40E2AC4965Q26863355-9BED7144-2D50-4181-B57A-7EFC0918E93BQ27002820-C50BAA73-61F9-496F-BFB3-DFA4F274E783Q28071455-313ECEAB-6C8E-48AD-8C09-0E607316CA56Q28082706-F6BE33FC-29AB-4CFE-92E8-AAD83FB19395Q30239085-34E107C0-86E9-4EDA-9D63-C2D047E3EC89Q30249670-3A80249F-E304-4AF7-8C3C-D197BCDD87CFQ30249760-ECBF51D6-FE9E-461B-B133-7BB9BB109291Q30988309-93001955-9E2C-44C2-BA86-E47650FA8BC7Q33585107-8A225821-D0CF-4F39-851C-EDB781EB2AFBQ33588303-C17119A7-35B0-481C-95E8-29B5336CA70EQ33728006-8AA1620A-0C8E-4C50-8ABF-811AD74A5338Q33760424-84EB8B2F-AD8F-4BA3-B2F9-ED453CC1CAC2Q34081859-C31E9D60-AA48-4C76-BFC0-32CE5C06C12EQ34088415-7B960E69-0101-42BC-9A7D-F6713F39243BQ34090556-038C9BCF-2198-425E-9C44-3DF3A7B3C5D4Q34199044-A47C0D97-A2E8-4388-9BE5-9750B4DC2CB0Q34297310-38FB3AAB-19DD-4BF6-A04C-3A16D4175E11Q34467757-253EDF3D-8FF2-4101-9433-026087BA11ABQ34978297-C36D2603-9A29-4B51-96D9-9001C60E1905Q35157966-ADD0936F-8F04-4C3B-A2E7-566C6199D834Q35241079-6658E8A0-D338-4044-A9DF-E8B07D0A92EDQ35544765-D2858B4D-B074-4A57-8466-252AD99CD62FQ35601538-2D5BFB59-BD71-4602-9821-05D18BB1A1D4Q35626714-10A94645-A05D-48CB-A778-379FC5A44474Q35733246-8A053C7A-7C4A-43EA-A97D-31AAFC24ACACQ35904559-0C5AA3E9-A755-430F-B5CC-BCC52A7E24B8Q35935833-4548BDC3-C52B-4744-9EB8-5FE2FC9687BDQ36082618-1C8662A4-A93F-4191-BF2D-8B5D78CB8888Q36165320-86FF52A2-FDA5-4A32-B8CB-7FBDD1D024F2Q36165912-68413FD3-66E5-476E-A9AD-5BE9C9319381Q36165958-97076430-CD64-4623-9706-8BC9A1CCF6B6Q36288030-997C4FB3-3245-4074-A75F-EA4D30894630Q36299981-E8B75A53-5C9E-4E66-903C-E040D297E14CQ36327652-1A97DA8B-798B-46F8-8B07-4B4EEE76BB85Q36350937-CA7F17FB-A0E2-420D-8927-AD6C9F1CA895Q36362144-952EED64-64A5-4F04-8AB2-20B93F8234F1Q36368676-00A63675-C6F1-437C-BA46-AFD2FF4A85F0
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Neonatal drug withdrawal.
@ast
Neonatal drug withdrawal.
@en
Neonatal drug withdrawal.
@nl
type
label
Neonatal drug withdrawal.
@ast
Neonatal drug withdrawal.
@en
Neonatal drug withdrawal.
@nl
prefLabel
Neonatal drug withdrawal.
@ast
Neonatal drug withdrawal.
@en
Neonatal drug withdrawal.
@nl
P2093
P356
P1433
P1476
Neonatal drug withdrawal.
@en
P2093
COMMITTEE ON DRUGS
COMMITTEE ON FETUS AND NEWBORN
Mark L Hudak
Rosemarie C Tan
P304
P356
10.1542/PEDS.2011-3212
P407
P577
2012-01-30T00:00:00Z